Yekaterina Chudnovsky - 05 Mar 2025 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role: Director, 10%+ Owner
Signature: /s/ Yekaterina Chudnovsky
Issuer symbol: ELTX
Transactions as of: 05 Mar 2025
Net transactions value: +$338,328
Form type: 4
Filing time: 07 Mar 2025, 16:06:57 UTC
Previous filing: 25 Nov 2024
Next filing: 20 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELTX	Common Stock	Conversion of derivative security	$20,338,329	+3,500,573	+183%	$5.81	5,416,212	05 Mar 2025	Held by GKCC, LLC	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELTX	Convertible Note (convertible into Common Stock)	Conversion of derivative security	$20,000,001	-3,442,341	-100%	$5.81	0	05 Mar 2025	Common Stock	3,442,341	$5.81	Held by GKCC, LLC	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC.
F2	The Convertible Note had a stated maturity date of February 15, 2026. The Convertible Note, including any accrued but unpaid interest, was converted into shares of Common Stock on March 5, 2025 at a conversion price of $5.81 per share.